These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1643823)

  • 1. Antibiotic susceptibilities of the Vibrionaceae to meropenem and other antimicrobial agents.
    Clark RB
    Diagn Microbiol Infect Dis; 1992 Jul; 15(5):453-5. PubMed ID: 1643823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meropenem and imipenem activity against Pseudomonas aeruginosa isolates from the MYSTIC Program.
    Turner PJ
    Diagn Microbiol Infect Dis; 2006 Nov; 56(3):341-4. PubMed ID: 17049798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of meropenem and other antimicrobial agents against uncommon gram-negative organisms.
    Clark RB; Joyce SE
    J Antimicrob Chemother; 1993 Aug; 32(2):233-7. PubMed ID: 8226425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative evaluation of in vitro activities of carbapenems against gram-negative pathogens: Turkish data of COMPACT study].
    Korten V; Söyletir G; Yalçın AN; Oğünç D; Dokuzoğuz B; Esener H; Ulusoy S; Tünger A; Aygen B; Sümerkan B; Arman D; Dizbay M; Akova M; Hasçelik G; Eraksoy H; Başaran S; Köksal I; Bayramoğlu G; Akalın H; Sınırtaş M
    Mikrobiyol Bul; 2011 Apr; 45(2):197-209. PubMed ID: 21644063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-vitro interactions of DX-8739, a new carbapenem, meropenem and imipenem with amikacin against multiresistant Pseudomonas aeruginosa.
    Giamarellos-Bourboulis EJ; Grecka P; Giamarellou H
    J Antimicrob Chemother; 1996 Aug; 38(2):287-91. PubMed ID: 8877544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative in vitro activity of Meropenem, Imipenem and Piperacillin/tazobactam against 1071 clinical isolates using 2 different methods: a French multicentre study.
    Joly-Guillou ML; Kempf M; Cavallo JD; Chomarat M; Dubreuil L; Maugein J; Muller-Serieys C; Roussel-Delvallez M
    BMC Infect Dis; 2010 Mar; 10():72. PubMed ID: 20298555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative in vitro antibacterial activity of the new carbapenem meropenem (SM-7338).
    Visser MR; Hoepelman IM; Beumer H; Rozenberg-Arska M; Verhoef J
    Eur J Clin Microbiol Infect Dis; 1989 Dec; 8(12):1061-4. PubMed ID: 2695328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibacterial activity of meropenem and selected comparative agents against anaerobic bacteria at seven North American centers.
    Sheikh W; Pitkin DH; Nadler H
    Clin Infect Dis; 1993 Jun; 16 Suppl 4():S361-6. PubMed ID: 8324148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Sensitivity of diarrhea organisms to nifuroxazide].
    Dodin A; Guillou M
    Bull Soc Pathol Exot Filiales; 1984; 77(3):295-7. PubMed ID: 6386203
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative in vitro activities of selected antimicrobial agents against Aeromonas species and Plesiomonas shigelloides.
    Reinhardt JF; George WL
    Antimicrob Agents Chemother; 1985 Apr; 27(4):643-5. PubMed ID: 4004196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The growth-inhibitory properties of meropenem against anaerobes of clinical importance.
    Watt B; Naden M
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():119-24. PubMed ID: 2808203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial activity of the new carbapenem biapenem compared to imipenem, meropenem and other broad-spectrum beta-lactam drugs.
    Sader HS; Jones RN
    Eur J Clin Microbiol Infect Dis; 1993 May; 12(5):384-91. PubMed ID: 8354307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility of bacterial isolates from Turkey--a report from the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) Program.
    Eraksoy H; Basustaoglu A; Korten V; Kurt H; Ozturk R; Ulusoy S; Yaman A; Yuce A; Zarakolu P;
    J Chemother; 2007 Dec; 19(6):650-7. PubMed ID: 18230545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro antibacterial activities of doripenem, imipenem, and meropenem against recent Streptococcus pneumoniae isolates.
    Baek JY; Ko KS; Kang CI; Song JH; Peck KR
    Diagn Microbiol Infect Dis; 2011 Nov; 71(3):297-300. PubMed ID: 21855246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Vibrio and aeromonad sensitivity to the vibriostatic O 129].
    Khaĭtovich AB; Ved'mina EA
    Antibiot Med Biotekhnol; 1987 Jun; 32(6):446-9. PubMed ID: 3631937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-vitro susceptibility of Haemophilus influenzae to meropenem compared with imipenem, five other beta-lactams, chloramphenicol and ciprofloxacin.
    Powell M; Seetulsingh P; Williams JD
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():175-81. PubMed ID: 2808206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting doripenem susceptibility based on meropenem and imipenem interpretation for Pseudomonas aeruginosa.
    Hagihara M; Kuti JL; Nicolau DP
    Diagn Microbiol Infect Dis; 2012 Mar; 72(3):258-62. PubMed ID: 22209563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of antibacterial activities of meropenem and six other antimicrobials against Pseudomonas aeruginosa isolates from North American studies and clinical trials.
    Iaconis JP; Pitkin DH; Sheikh W; Nadler HL
    Clin Infect Dis; 1997 Feb; 24 Suppl 2():S191-6. PubMed ID: 9126693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antimicrobial activity of carbapenems and the combined effect with aminoglycoside against recent clinical isolates of Pseudomonas aeruginosa].
    Tasaka K; Ishida A; Chinzei T
    Jpn J Antibiot; 2002 Apr; 55(2):181-6. PubMed ID: 12071095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the vitek 2 AST-N269 card for detection of meropenem resistance in imipenem-susceptible meropenem-resistant Enterobacteriaceae.
    Koizumi A; Kasahara K; Komatsu Y; Ui K; Mizuno F; Nakayama A; Mikasa K
    J Clin Microbiol; 2013 Nov; 51(11):3908. PubMed ID: 23966492
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.